Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Through a website called Stories of Women in Neuroscience, Nancy Padilla-Coreano aims to shift biases in the field, one conversation at a time.

A researcher’s existential crisis led to a scientific breakthrough.

Women who carry genetic variants tied to autism have an elevated chance of experiencing pregnancy-related events linked to the condition in their children.

People’s brains have a larger network of inhibitory interneurons than mouse brains do, according to a new study. Changes to that network could contribute to autism or other conditions, says lead investigator Moritz Helmstaedter.

Twitter was not quiet as a mouse this week over two animal studies, a survey of cannabis use by autistic people, and a big announcement from the Journal of Neuroscience.

Here is a roundup of news and research for the week of 25 July.

By breaking rodent vocalizations into parts, TrackUSF distinguishes rats with mutations in the SHANK3 gene from their wildtype counterparts.

Most autistic children in the Netherlands have used some sort of treatment, but the number, type and timing varies depending on considerations unrelated to their condition.

Regions of the brain’s fear center expand in autistic children and teenagers with anxiety, but not in their autistic or non-autistic peers without anxiety.